A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D.

PubWeight™: 5.19‹?› | Rank: Top 1%

🔗 View Article (PMID 15436997)

Published in J Immunol on August 01, 1950

Authors

M STERNE, L M WENTZEL

Articles citing this

Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26

Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44

Comparison of two toxins produced by Clostridium difficile. Infect Immun (1981) 5.16

Dialysis culture of microorganisms: design, theory, and results. Bacteriol Rev (1969) 4.14

Classification of intestinomotor drugs by means of type D botulinum toxin. J Physiol (1955) 4.11

Study of toxins of Clostridium botulinum. III. Relation of autolysis to toxin production. J Bacteriol (1955) 3.50

Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40

Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Appl Microbiol (1972) 2.32

PREPARATION AND ASSAY OF THE INTERNATIONAL STANDARDS FOR CLOSTRIDIUM BOTULINUM TYPES A, B, C, D AND E ANTITOXINS. Bull World Health Organ (1963) 2.30

Isolation and molecular size of Clostridium botulinum type C toxin. Appl Environ Microbiol (1977) 1.94

Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun (1996) 1.82

Sporulation of Clostridium botulinum types A, B, and E, Clostridium perfringens, and putrefactive anaerobe 3679 in dialysis sacs. J Bacteriol (1963) 1.67

Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun (1987) 1.57

Molecular basis for the pathological actions of Clostridium perfringens iota toxin. Infect Immun (1987) 1.47

Studies on immunity to toxins of Clostridium botulinum. IV. Production and purification of type C toxin for conversion to toxoid. J Bacteriol (1958) 1.40

The quantitative determination of diffusible histamine in blood. Br J Pharmacol Chemother (1952) 1.37

Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid. J Bacteriol (1960) 1.20

Production by Clostridium spiroforme of an iotalike toxin that possesses mono(ADP-ribosyl)transferase activity: identification of a novel class of ADP-ribosyltransferases. Infect Immun (1989) 1.09

Culture of Clostridium botulinum type C with controlled pH. J Bacteriol (1958) 1.09

Distribution of botulinum toxin-producing clostridia in soils of Argentina. Appl Environ Microbiol (2005) 0.93

Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B. Infect Immun (1976) 0.91

Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia. Infect Immun (2003) 0.85

Toxoid of Clostridium botulinum type F: purification and immunogenicity studies. Appl Environ Microbiol (1976) 0.84

Characterization of the neurotoxin isolated from a Clostridium baratii strain implicated in infant botulism. Infect Immun (1992) 0.82

Studies of the toxin of Clostridium botulinum. V. Prophylactic immunization of pheasants and ducks against avian botulism. J Bacteriol (1959) 0.75

Studies of toxins of Clostridium botulinum. II. Immunization of rabbits with an atoxic variant of Clostridium botulinum, type C. J Bacteriol (1954) 0.75